Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher

This cohort study investigates the association of overall survival with receiving chemotherapy among patients with early-stage breast cancer and recurrence scores of 26 to 30 vs those with recurrence scores of 31 or greater.

Detalles Bibliográficos
Autores principales: Ma, Sung Jun, Oladeru, Oluwadamilola T., Singh, Anurag K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199111/
https://www.ncbi.nlm.nih.gov/pubmed/32364592
http://dx.doi.org/10.1001/jamanetworkopen.2020.3876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199111/
https://www.ncbi.nlm.nih.gov/pubmed/32364592
http://dx.doi.org/10.1001/jamanetworkopen.2020.3876

Ejemplares similares